FARICIMAB vs FEBUXOSTAT: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
FARICIMAB vs FEBUXOSTAT: Safety Overview
| Metric | FARICIMAB | FEBUXOSTAT |
|---|---|---|
| Total FAERS Reports | 381 | 5,843 |
| Deaths Reported | 23 | 404 |
| Death Rate | 6.0% | 6.9% |
| Hospitalizations | 98 | 1,755 |
| Average Patient Age | 69.6 yrs | 66.7 yrs |
| % Female Patients | 51.2% | 31.6% |
| FDA Approval Date | N/A | Dec 19, 2023 |
| Manufacturer | Genentech, Inc. | Novadoz Pharmaceuticals LLC |
| Route | INTRAVITREAL | ORAL |
| Marketing Status | N/A | Prescription |